91 related articles for article (PubMed ID: 7029282)
21. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal anti-T12 antibody as therapy for renal allograft rejection.
Carpenter CB; Milford EL; Reinherz EL; Schlossman SF; Tilney NL; Strom TB; Kirkman RL; Busch GJ; Araujo JL
Trans Assoc Am Physicians; 1983; 96():84-92. PubMed ID: 6388105
[TBL] [Abstract][Full Text] [Related]
23. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
[No Abstract] [Full Text] [Related]
24. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
[TBL] [Abstract][Full Text] [Related]
26. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
Waid TH; Lucas BA; Amlot P; Janossy G; Yacoub M; Cammisuli S; Jezek D; Rhoades J; Brown S; Thompson JS
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
[TBL] [Abstract][Full Text] [Related]
27. Anti-T12 monoclonal antibody therapy of acute renal allograft rejection.
Milford EL; Carpenter CB; Kirkman RL; Tilney NL; Mazoujian G; Strom TB; Lazarus JM; Schlossman SF; Guttmann RD; Lowry R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1910. PubMed ID: 3274450
[No Abstract] [Full Text] [Related]
28. Non-complement-fixing antibodies as indicators for impending renal allograft rejection.
Daniel V; Berteli AJ; Röhl L; Pomer S; Opelz G
Transplant Proc; 1989 Feb; 21(1 Pt 1):702-3. PubMed ID: 2650231
[No Abstract] [Full Text] [Related]
29. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
[No Abstract] [Full Text] [Related]
30. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
31. Ability of a CD4-positive, MRC OX22 "low" T-cell subpopulation to initiate renal allograft rejection in the athymic nude rat.
Bradley JA; Bolton EM; Briggs JD; Gracie JA
Transplant Proc; 1989 Feb; 21(1 Pt 1):326-7. PubMed ID: 2650138
[No Abstract] [Full Text] [Related]
32. Immunologic monitoring with monoclonal antibodies to human T-cell subsets.
Cosimi AB; Colvin RB; Burton RC; Winn HJ; Rubin R; Goldstein G; Kung PC; Hoffman RA; Hansen WP; Russell PS
Transplant Proc; 1981 Sep; 13(3):1589-93. PubMed ID: 7029820
[No Abstract] [Full Text] [Related]
33. Monoclonal antibody identification of nucleated cells in urine: diagnosis of allograft rejection.
Segasothy M; Birch DF; Fairley KF; Kincaid-Smith P
Transplant Proc; 1989 Feb; 21(1 Pt 2):1878-9. PubMed ID: 2652610
[No Abstract] [Full Text] [Related]
34. The effects of OKT3 anti-rejection therapy on in situ allograft infiltrating lymphocytes.
Kerr PG; Atkins RC
Transplant Proc; 1989 Feb; 21(1 Pt 1):977-8. PubMed ID: 2650302
[No Abstract] [Full Text] [Related]
35. Studies on chromosome aberrations of peripheral T lymphocytes in cadaveric kidney allograft recipients.
Ding Z
Transplant Proc; 1989 Feb; 21(1 Pt 3):3205-8. PubMed ID: 2650453
[No Abstract] [Full Text] [Related]
36. The clinical role of OKT3.
Norman DJ
Cardiol Clin; 1990 Feb; 8(1):97-105. PubMed ID: 2407364
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects.
Chatenoud L
Transplant Proc; 1988 Oct; 20(5 Suppl 6):79-83. PubMed ID: 3140452
[No Abstract] [Full Text] [Related]
38. Anti-B lymphocytotoxins in renal-allograft rejection.
Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
[TBL] [Abstract][Full Text] [Related]
39. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
Sengar DP; Rashid A; Harris JE
Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
[TBL] [Abstract][Full Text] [Related]
40. Different functional activities of T cell lines isolated from a rejected renal allograft and peripheral blood lymphocytes of renal transplant recipients.
Miltenburg AM; Meijer-Paape ME; Daha MR; Paul LC
Transplant Proc; 1988 Apr; 20(2):298-9. PubMed ID: 2966469
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
